Skip to main navigation
Join Our Team
Contact Us
Company
Our Purpose
Company History
Leadership Team
Board
of
Directors
Partnership Opportunities
Corporate Compliance
Exhalation
Delivery Systems
Liquid Delivery
Powder Delivery Device
Anatomy
of the
Nasal Passages
Nasal Delivery Challenges
Therapeutic
Areas
Products
XHANCE
®
ONZETRA
®
Xsail
®
Research &
Development
XHANCE
®
- Future Development
Partnerships
Investors
News & Events
Stock Information
Corporate Governance
SEC Filings
Proxy Materials
Investor Resources
News &
Media
Scientific
Communications
Peer-Reviewed Journal Publications
Event Details
Optinose Q3 2022 Earnings Call
Thursday, November 10, 2022
at 8:00 AM EST
Listen to Webcast
Investors
News & Events
Stock Information
Corporate Governance
SEC Filings
Proxy Materials
Investor Resources
Toolkit
Print page
Sign up for email alerts
Investor Contact
Jonathan Neely
VP Investor Relations and Business Operations
Email:
investors@optinose.com
